[{"address1": "55 Greens Farms Road", "address2": "1st Floor", "city": "Westport", "state": "CT", "zip": "06880", "country": "United States", "phone": "203 409 5444", "fax": "203 429 5044", "website": "https://www.biosig.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Frederick D. Hrkac", "age": 57, "title": "President, Principal Executive Officer, Executive VP & Director", "yearBorn": 1966, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony  Amato", "age": 55, "title": "CEO, Chairman & Member of Advisory Board", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ferdinand  Groenewald", "age": 39, "title": "Interim CFO & Principal Accounting Officer", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Budimir S. Drakulic Ph.D.", "age": 73, "title": "Chief Scientist", "yearBorn": 1950, "fiscalYear": 2012, "totalPay": 169644, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1356912000, "maxAge": 86400, "priceHint": 4, "previousClose": 0.931, "open": 0.9011, "dayLow": 0.9, "dayHigh": 1.07, "regularMarketPreviousClose": 0.931, "regularMarketOpen": 0.9011, "regularMarketDayLow": 0.9, "regularMarketDayHigh": 1.07, "beta": 0.353, "forwardPE": -1.2449315, "volume": 238364, "regularMarketVolume": 238364, "averageVolume": 215316, "averageVolume10days": 125200, "averageDailyVolume10Day": 125200, "bid": 0.8751, "ask": 0.9454, "bidSize": 200, "askSize": 100, "marketCap": 15663077, "fiftyTwoWeekLow": 0.201, "fiftyTwoWeekHigh": 2.98, "priceToSalesTrailing12Months": 391.57693, "fiftyDayAverage": 1.35116, "twoHundredDayAverage": 0.983105, "currency": "USD", "enterpriseValue": 27926590, "floatShares": 11560230, "sharesOutstanding": 17234900, "sharesShort": 183442, "sharesShortPriorMonth": 514310, "sharesShortPreviousMonthDate": 1714435200, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0113, "heldPercentInsiders": 0.30769, "shortRatio": 0.56, "shortPercentOfFloat": 0.0127, "impliedSharesOutstanding": 17618000, "bookValue": -0.334, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -18075000, "trailingEps": -1.34, "forwardEps": -0.76, "lastSplitFactor": "1:10", "lastSplitDate": 1706832000, "enterpriseToRevenue": 698.165, "enterpriseToEbitda": -1.519, "52WeekChange": 0.042648673, "SandP52WeekChange": 0.21142256, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BSGM", "underlyingSymbol": "BSGM", "shortName": "BioSig Technologies, Inc.", "longName": "BioSig Technologies, Inc.", "firstTradeDateEpochUtc": 1414762200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "48037ce3-39cc-383a-80c7-f12bf21a8330", "messageBoardId": "finmb_140829557", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.9088, "targetHighPrice": 2.75, "targetLowPrice": 2.75, "targetMeanPrice": 2.75, "targetMedianPrice": 2.75, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 2104000, "totalCashPerShare": 0.129, "ebitda": -18382000, "totalDebt": 282000, "quickRatio": 0.747, "currentRatio": 0.802, "totalRevenue": 40000, "debtToEquity": 243.103, "revenuePerShare": 0.004, "returnOnAssets": -3.2649899, "returnOnEquity": -63.420288, "grossProfits": 40000, "freeCashflow": -4396750, "operatingCashflow": -9565000, "grossMargins": 1.0, "operatingMargins": -407.0769, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-08"}]